How to navigate China’s regulatory environment
Hear Parexel’s China Regulatory experts share their assessment of the current landscape, registration and regulatory pathways, and offer practical advice on CDE meetings and HDA communication.
Related Insights
Playbook
Preparing clinical infrastructure for radiopharmaceutical trials
Mar 11, 2026
Blog
New guideline for the management of Systemic Lupus Erythematosus (SLE): Considerations for clinical development
Jan 12, 2024
Blog
Population variability: important considerations in vaccine development
Jun 14, 2023
Whitepaper
How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU
Jun 28, 2023
Article
The technologies that are reshaping biotherapeutics manufacturing, an EU perspective
Jul 6, 2023
Blog
Ensuring future success in a new market by delivering a robust safety database solution
Aug 4, 2023
Whitepaper
Optimizing the Route to Regulatory Approval for a Novel Vaccine
Aug 18, 2023
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Whitepaper
Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)
Sep 19, 2023
Blog
Assessing the need for comparative clinical trials in biosimilar development programs
Sep 21, 2023
Whitepaper
Advancing clinical development through innovative trial design
Nov 3, 2023
Webinar
Breakthrough Devices Program: Where’s the value?
Nov 13, 2023
Related Insights
Playbook
Preparing clinical infrastructure for radiopharmaceutical trials
Mar 11, 2026
Blog
New guideline for the management of Systemic Lupus Erythematosus (SLE): Considerations for clinical development
Jan 12, 2024
Blog
Population variability: important considerations in vaccine development
Jun 14, 2023
Whitepaper
How to prepare for Policy 0070: Challenges and opportunities for clinical data publication in the EU
Jun 28, 2023
Article
The technologies that are reshaping biotherapeutics manufacturing, an EU perspective
Jul 6, 2023
Blog
Ensuring future success in a new market by delivering a robust safety database solution
Aug 4, 2023
Whitepaper
Optimizing the Route to Regulatory Approval for a Novel Vaccine
Aug 18, 2023
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Whitepaper
Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)
Sep 19, 2023
Blog
Assessing the need for comparative clinical trials in biosimilar development programs
Sep 21, 2023
Whitepaper
Advancing clinical development through innovative trial design
Nov 3, 2023
Webinar
Breakthrough Devices Program: Where’s the value?
Nov 13, 2023